| J2350 | Injection, ocrelizumab, 1 mg | 16,800 | $40 | $705.6K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 22,000 | $10 | $110K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 490 | $130 | $63K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 650 | $90 | $58.3K |
| 95886 | The provider assesses the electrical activity of a muscle in the extremity and related paraspinal areas. At the same session as a separately reportable nerve conduction study. He studies five or more… | 550 | $80 | $41.1K |
| 95911 | In this procedure, the provider performs nine or ten nerve conduction studies, a diagnostic test to evaluate function, especially the electrical conduction ability of the motor and sensory nerves of… | 180 | $160 | $29.6K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 160 | $160 | $26.4K |
| 95912 | In this procedure, the provider performs eleven or twelve nerve conduction studies, a diagnostic test to evaluate function, especially the electrical conduction ability of the motor and sensory… | 110 | $190 | $20.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 200 | $100 | $20.1K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 120 | $140 | $17.1K |